Advanced Modalities
Analytical & Bioanalytical Services
Company Overview
About
OmniaBio Inc is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Gene Therapy, Cell Therapy, mRNA
Therapeutic Areas
Oncology
Hematology
Quick Facts
HQ:Canada
Founded:2006
Employees:315
Capabilities & Services
Core Capabilities
- Oral Solid Dose
- Solid Dose Manufacturing
- Formulation Development
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Lyophilized (Freeze-Dried)
Sterile Injectable
Containment Capabilities
Cytotoxic / ADC Handling
Production Scales
Phase III Clinical Trials
Commercial Scale
Clinical
Markets Served
North America
Regulatory Approvals
Drug Approval 1LTHOW
PMDA · #APR-SAA4Q0EH · 2020-04-01
Drug Approval CKRG2L
EMA · #APR-LKOVTZZM · 2022-10-01
Certifications
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-8BJ4GEOP
Issued: 2020-02-18
Expires: 2025-05-01
WHO GMP
World Health Organization
Cert #: CERT-LX3OC50B
Issued: 2020-05-14
Expires: 2025-08-13
MHRA GMP
UK Medicines and Healthcare products Regulatory Agency
Cert #: CERT-XNECWSPT
Issued: 2020-10-08
Expires: 2025-12-26
Loading CDMO intelligence...
Key facts about OmniaBio Inc
- OmniaBio Inc is headquartered in Canada.
- OmniaBio Inc was founded in 2006.
- OmniaBio Inc has 315 employees.
- OmniaBio Inc's capabilities include Oral Solid Dose, Solid Dose Manufacturing and Formulation Development.
Find CDMOs like OmniaBio Inc
Directory pages this company appears in, each with the full list of matching manufacturers.